SEO URLwww.firestrike.ai/deals/biocon-biocon-biologics-acquisition-2026
acquisitionAnnounced · Feb 12, 2026BiotechnologySource · CredibleArticle · Factual
Biocon Biologics acquires Biocon
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$5.5B
Target
Biocon
NSE: BIOCON.NS · Wipro Limited, Karnataka
Acquirer
Biocon Biologics
Full Acquisition
Status
Announced
Biocon Biologics agreed to acquire Biocon. Reported deal value: $5.5B. Status: Announced. Sector: Biotechnology. Target headquarters context: Wipro Limited, Karnataka, India.
This page summarizes publicly available information about the transaction as of 2026-02-12. Figures and status may change as filings and press coverage update.
Critically, the Board also granted in-principle approval to acquire the remaining ~2% equity share capital of its material subsidiary, Biocon Biologics Limited , from employees and other shareholders, paving the way for BBL to become a wholly-owned subsidiary
Deal timeline
Announced
Feb 12, 2026 · investywise.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Biotechnology with a reported deal value of $5.5B. Figures and status may change as sources update.
Sources: investywise.com · Primary article · FireStrike proprietary index